A whole organism small molecule screen identifies novel regulators of pancreatic endocrine development

Christian S. M. Helker, Sri-teja Mullapudi, Laura M. Mueller, Jens Preussner, Sorin Tunaru, Oskar Skog, Hyouk-bum Kwon, Florian Kreuder, Joseph J. Lancman, Remy Bonnavion, P. Duc Si Dong, Mario Looso, Stefan Offermanns, Ole Korsgren, Francesca M. Spagnoli, Didier Y. R. Stainier

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)
110 Downloads (Pure)


An early step in pancreas development is marked by the expression of the Pdx1 transcription factor within the pancreatic endoderm where it is required for the specification of all endocrine cell types. Subsequently, Pdx1 expression becomes restricted to the β-cell lineage where it plays a central role in β-cell function. This pivotal role of Pdx1 at various stages of pancreas development makes it an attractive target to enhance pancreatic β-cell differentiation and increase β-cell function. In this study, we used a newly generated zebrafish reporter to screen over 8,000 small molecules for modulators of pdx1 expression. We found four hit compounds and validated their efficacy at different stages of pancreas development. Valproic acid (VPA), a HDAC inhibitor, induces pancreatic endoderm formation, while inhibition of TGF-β signaling leads to the transdifferentiation of α-cells to β-cells. HC Toxin, another HDAC inhibitor, enhances β-cell function in primary mouse and human islets. Thus, using a whole-organism screening strategy, this study identified new pdx1 expression modulators which can be used to influence different steps in pancreas and β-cell development.
Original languageEnglish
Article numberdev172569
Pages (from-to)dev.172569
JournalDevelopment (Cambridge): for advances in developmental biology and stem cells
Issue number14
Early online date29 May 2019
Publication statusPublished - 1 Jul 2019


  • Pdx1
  • Small molecule screen
  • Transdifferentiation
  • α-Cells
  • β-Cells


Dive into the research topics of 'A whole organism small molecule screen identifies novel regulators of pancreatic endocrine development'. Together they form a unique fingerprint.

Cite this